抵克立得

抗血小板药物抵克立得在急性冠脉综合征治疗中对患者内源性纤溶系统影响的临床研究

Effects of Antiplatelet Drug Ticlid on the Endogenous Fibrinolytic System in Patients with Acute Coronary Syndrome Undergoing Therapy

银杏黄酮甙与抵克立得治疗原发性肾病综合征高凝状态的临床研究

Clinical Research on the Treatment of Hypercoagulable State in Primary Nephrotic Syndrome by Ginko flavonoid glycoside Tablet and Ticlid

方法：44例高血粘度的2型糖尿病患者口服抵克立得片250mg，qd，疗程2周。

METHODS : 44 patients with high blood viscosity were treated with ticlopidine in a dose of 250 mg daily for 14 days .

采用开放型单向序贯设计，检测了小剂量、短疗程抵克立得治疗对ADP诱导的血小板聚集性的影响。

Open sided sequential design adopted in the present study to examine the effects of short course treatment with ticlopidine no platelet aggregation induced by adenosine diphosphate ( ADP ) at low doses .

异舒吉联合抵克立得肝素治疗不稳定心绞痛的临床观察

Clinical observation of Isoket , Ticlid and Heparin in combination treatment of instable angina pectoris